Taken together, these results indicate that the degradation of EGF-stimulated EGFR occurs via the endosomal–lysosomal pathway in both cell lines, although the binding of EGF to its receptor is reduced in DM1 cells. The gene discussed is EGF; the disease is myotonic dystrophy type 1.